Logo Amazing ErasmusMC
NL
  • Homepage
  • Erasmus MC
  • Cookies
  • Disclaimer
  • Privacy

Urology

Christiaan de Jong en Tahlita Zuiverloon

Bladder cancer

PCR test on bladder tumor predicts response to treatment

With a relatively simple test, urologists may be able to accurately determine in the future which patients will benefit from BCG bladder instillations. This is important because in 40 percent of patients, treatment is not successful, while treatment duration is lengthy and can cause unpleasant side effects.

organoid bladder cancer

Urology

$3 million for research on bladder cancer and chemotherapy

American bladder cancer scientists have been awarded the prestigious R01 grant, together with urologist Dr. Tahlita Zuiverloon of the Erasmus MC Cancer Institute. The team will receive $3 million for research into the biology of chemotherapy resistance in bladder cancer.

Picture 043

Tumor DNA

Blood test should predict whether immunotherapy will work in bladder cancer

A blood test can help to predict whether immunotherapy will be effective in patients with metastatic bladder cancer. This is evident from research by internist-oncologist Debbie Robbrecht from the Erasmus MC Cancer Institute.

IV

Pembrolizumab

Immune therapy prevents bladder removal for some bladder cancer patients

A proportion of patients with difficult-to-treat non-metastatic bladder cancer benefit from immunotherapy with the drug pembrolizumab. This has been shown by international research, which Erasmus MC Cancer Institute co-led. Annually, researchers estimate this new therapy could save about 50 patients in the Netherlands from having their bladder removed.

Erasmus MC
  • Amazing Erasmus MC
  • Erasmus MC
  • Follow us
  • Facebook
  • Instagram
  • Twitter
  • LinkedIn
  • © 2025 Erasmus MC
  • Cookies
  • Disclaimer
  • Privacy